Commentary discusses PBM effectiveness in managing drug access and costs, suggesting further exploration of market dynamics.
Key Points
This commentary critiques the role of pharmacy benefit managers (PBMs) in managing pharmaceutical access and costs, highlighting gaps in current research.
Reviewed models by Ho and Lee on PBM tiered formularies and payor savings.
Discussed the impact of patient demand inertia on PBM pricing strategies.
Analyzed formulary auctions and PBM induced pricing dynamics.
PBMs' tiered formularies generate significant payor savings through competition.